Dr Khaliq joined Global Medical Affairs at AstraZeneca in October 2013 leading the medical affairs strategies in breast cancer and medullary thyroid cancer. He is also currently leading the formulation of a medical affairs strategy in squamous cell carcinoma of the head and neck.

Dr Khaliq believes firmly and is committed to “building internal medical and scientific capability within AstraZeneca by developing strong relationships with external disease area experts and collaborative clinical research groups, in turn delivering key medical evidence generation programs for our medicines that will bring benefit to patients.